Axsome Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.
CEOHerriott Tabuteau
CEOHerriott Tabuteau
Employees683
Employees683
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2012
Founded2012
Employees683
Employees683
AXSM Key Statistics
Market cap7.40B
Market cap7.40B
Price-Earnings ratio-31.43
Price-Earnings ratio-31.43
Dividend yield—
Dividend yield—
Average volume444.49K
Average volume444.49K
High today—
High today—
Low today—
Low today—
Open price$146.76
Open price$146.76
Volume0.00
Volume0.00
52 Week high$152.94
52 Week high$152.94
52 Week low$75.56
52 Week low$75.56
Stock Snapshot
The current Axsome Therapeutics(AXSM) stock price is $146.87, with a market capitalization of 7.4B. The stock trades at a price-to-earnings (P/E) ratio of -31.43.
Axsome Therapeutics(AXSM) stock opened on 2025-12-17 at $146.76. The price climbed to — and dipped to —.
Axsome Therapeutics(AXSM) shares are trading with a volume of 0, against a daily average of 444.49K.
During the past year, Axsome Therapeutics(AXSM) stock moved between $75.56 at its lowest and $152.94 at its peak.
During the past year, Axsome Therapeutics(AXSM) stock moved between $75.56 at its lowest and $152.94 at its peak.
Analyst ratings
100%
of 21 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AXSM. This list is generated using Robinhood data, and it’s not a recommendation.